Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Cannabinoid receptor 2 (CB2) is highly expressed in immune cells and stimulation decreases inflammatory responses. We tested the idea that selective CB2 activation in human monocytes suppresses their ability to engage the brain endothelium and migrate across the blood-brain barrier (BBB), preventing consequent injury. Intravital videomicroscopy was used to quantify adhesion of leukocytes to cortical vessels in lipopolysaccharide-induced neuroinflammation, after injection of ex vivo CB2-activated leukocytes into mice; CB2 agonists markedly decreased adhesion of ex vivo labeled cells in vivo. In an in vitro BBB model, CB2 activation in monocytes largely attenuated adhesion to and migration across monolayers of primary human brain microvascular endothelial cells and diminished BBB damage. CB2 stimulation in monocytes down-regulated active forms of integrins, lymphocyte function-associated antigen 1 (LFA-1), and very late antigen 4 (VLA-4). Cells treated with CB2 agonists exhibited increased phosphorylation levels of inhibitory sites of the actin-binding proteins cofilin and VASP, which are upstream regulators of conformational integrin changes. Up-regulated by relevant stimuli, Rac1 and RhoA were suppressed by CB2 agonists in monocytes. CB2 stimulation decreased formation of lamellipodia, which play a key role in monocyte migration. These results indicate that selective CB2 activation in leukocytes decreases key steps in monocyte-BBB engagement, thus suppressing inflammatory leukocyte responses and preventing neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354 · cited 1×
“18,19 Circulating leukocytes are recruited to sites of injury, infection, and in fl ammation by well-coordinated sequential steps (including tethering, rolling, arrest, fi rm adhesion, and migration across the endothelium 20,21 ) mediated by selectin and integrin proteins.”
BackgroundMonocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015 · cited 1×
“31 e 33,38,39 However, these studies did not address how much of the effects of CB2 activation apply to immune cells or endothelium (or both), nor did they address the underlying mechanisms.”
BackgroundCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Shechter, R., London, A., Varol, C., Raposo, C., Cusimano, M., Yovel, G., Rolls, A., Mack, M., Pluchino, S., Martino, G., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000113 · Cited by 770 · cited 1×
“Extensive data suggest that microglial activity is not always adequate to support repair of the central nervous system and that recruitment of myeloid cells (M2) from the blood stream contributes to recovery after spinal cord injury.(12) Microglia restricted amyloid-β plaques in a mouse model of Alzheimer’s disease(13…”
BackgroundADF/Cofilin: a functional node in cell biology
Bernstein, B. W., & Bamburg, J. R. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.001 · Cited by 704 · cited 1×
“54 We therefore tested the effects of CB2 activation on p-S3-co fi lin levels in U937 cells and found increased levels of p-S3-co fi lin in CB2 agonist-treated cells (Figure 7).”
BackgroundType II monocytes modulate T cell–mediated central nervous system autoimmune disease
Weber, M. S., Prod'homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., Patarroyo, J. C., Stüve, O., Sobel, R. A., Steinman, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1620 · Cited by 447 · cited 1×
“15 However, because the CNS is an immune privileged site, it is assumed to exclude excessive leukocyte traf fi cking, 16,17 especially the proin fl ammatory (M1) type, which is prevalent during infection.”
BackgroundSignaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation
Mizuno, K. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2012.11.001 · Cited by 396
Stamatovic, S. M., Keep, R. F., Kunkel, S. L., & Andjelkovic, A. V. (2003) · Journal of Cell Science · doi:10.1242/jcs.00755 · Cited by 381
London, A., Cohen, M., & Schwartz, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00034 · Cited by 282 · cited 1×
“12 Microglia restricted amyloid-b plaques in a mouse model of Alzheimer ’ s disease 13,14 and reversed paralysis in an experimental autoimmune encephalomyelitis model for multiple sclerosis.”
BackgroundHan, K. H., Lim, S., Ryu, J., Lee, C.-W., Kim, Y., Kang, J.-H., Kang, S.-S., Ahn, Y. K., Park, C.-S., & Kim, J. J. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp240 · Cited by 232 · cited 1×
“30 31 e 35 We hypothesized that CB2 on leukocytes could serve as a target for the anti-in fl ammatory effects of CB2 agonists via decreasing leukocyte engagement of endothelium and BBB injury.”
Background
Cited by
Bernstein, D. L., Zuluaga-Ramirez, V., Gajghate, S., Reichenbach, N. L., Polyak, B., Persidsky, Y., & Rom, S. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19882264 · Cited by 120
“TEER measurements were performed using the 1600R ECIS System (Applied Biophysics) as described.(9,15,16) The results are presented as an average of the resistance values (Ohm, ) as well as the average percent change from baseline TEER (expressed as average SD) from at least three independent experiments consisting of…”
MethodSelf-citationmiR-98 and let-7g* protect the blood-brain barrier under neuroinflammatory conditions
Rom, S., Dykstra, H., Zuluaga-Ramirez, V., Reichenbach, N. L., & Persidsky, Y. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.154 · Cited by 118
Self-citationGui, H., Liu, X., Liu, L.-R., Su, D.-F., & Dai, S.-M. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.12.012 · Cited by 60
Argue, K. J., VanRyzin, J. W., Falvo, D. J., Whitaker, A. R., Yu, S. J., & McCarthy, M. M. (2017) · eneuro · doi:10.1523/eneuro.0344-16.2017 · Cited by 47
“Modulation of the endocannabinoid system may also directly induce changes to the blood–brain barrier (Engelhardt, 2003; Rom et al., 2013; Vendel and de Lange, 2014), thereby altering the inflammatory status of the brain, without acting on receptors located within the CNS.”
Background
Metadata
- Authors
- Rom, S., Zuluaga-Ramirez, V., Dykstra, H., Reichenbach, N. L., Pacher, P., & Persidsky, Y.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 183
- Issue
- 5
- Pages
- 1548-1558
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2096973688
- Cited by
- 70
- References
- 10
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.